DNTH logo

Dianthus Therapeutics (DNTH) Cash From Operations

Annual CFO

-$36.86 M
-$7.79 M-26.80%

December 31, 2023


Summary


Performance

DNTH Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDNTHcash flowmetrics:

Quarterly CFO

-$21.27 M
-$6.74 M-46.39%

September 30, 2024


Summary


Performance

DNTH Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDNTHcash flowmetrics:

TTM CFO

-$62.59 M
-$11.28 M-21.97%

September 30, 2024


Summary


Performance

DNTH TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDNTHcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

DNTH Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-26.8%-112.8%-150.3%
3 y3 years-272.2%-112.8%-150.3%
5 y5 years-272.2%-112.8%-150.3%

DNTH Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-272.2%at low-349.5%at low-209.6%at low
5 y5-year-272.2%at low-349.5%at low-209.6%at low
alltimeall time-272.2%at low-349.5%at low-209.6%at low

Dianthus Therapeutics Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$21.27 M(+46.4%)
-$62.59 M(+22.0%)
Jun 2024
-
-$14.53 M(-2.8%)
-$51.31 M(+23.6%)
Mar 2024
-
-$14.94 M(+26.0%)
-$41.52 M(+12.6%)
Dec 2023
-$36.86 M
-$11.85 M(+18.6%)
-$36.86 M(+47.4%)
Sep 2023
-
-$9.99 M(+111.2%)
-$25.01 M(-29.0%)
DateAnnualQuarterlyTTM
Jun 2023
-
-$4.73 M(-54.0%)
-$35.23 M(+15.5%)
Mar 2023
-
-$10.28 M(-49.1%)
-$30.50 M(+50.9%)
Dec 2022
-$29.07 M(+193.5%)
-
-
Sep 2022
-
-$20.22 M
-$20.22 M
Dec 2021
-$9.90 M
-
-

FAQ

  • What is Dianthus Therapeutics annual cash flow from operations?
  • What is the all time high annual CFO for Dianthus Therapeutics?
  • What is Dianthus Therapeutics annual CFO year-on-year change?
  • What is Dianthus Therapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Dianthus Therapeutics?
  • What is Dianthus Therapeutics quarterly CFO year-on-year change?
  • What is Dianthus Therapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for Dianthus Therapeutics?
  • What is Dianthus Therapeutics TTM CFO year-on-year change?

What is Dianthus Therapeutics annual cash flow from operations?

The current annual CFO of DNTH is -$36.86 M

What is the all time high annual CFO for Dianthus Therapeutics?

Dianthus Therapeutics all-time high annual cash flow from operations is -$9.90 M

What is Dianthus Therapeutics annual CFO year-on-year change?

Over the past year, DNTH annual cash flow from operations has changed by -$7.79 M (-26.80%)

What is Dianthus Therapeutics quarterly cash flow from operations?

The current quarterly CFO of DNTH is -$21.27 M

What is the all time high quarterly CFO for Dianthus Therapeutics?

Dianthus Therapeutics all-time high quarterly cash flow from operations is -$4.73 M

What is Dianthus Therapeutics quarterly CFO year-on-year change?

Over the past year, DNTH quarterly cash flow from operations has changed by -$11.28 M (-112.84%)

What is Dianthus Therapeutics TTM cash flow from operations?

The current TTM CFO of DNTH is -$62.59 M

What is the all time high TTM CFO for Dianthus Therapeutics?

Dianthus Therapeutics all-time high TTM cash flow from operations is -$20.22 M

What is Dianthus Therapeutics TTM CFO year-on-year change?

Over the past year, DNTH TTM cash flow from operations has changed by -$37.58 M (-150.29%)